David H. Lifschutz, MD, FAPA, is a top psychoanalyst and psychiatrist who lends his skills and expertise to serve patients at his private practice in Upper East Side on Manhattan in New York, NY 10029. He additionally can be found on staff at Mount Sinai Beth Israel Hospital. With forty-eight years of experience as a psychiatrist, he specializes in ketamine-assisted psychotherapy (KAP), psychopharmacology, and psychedelic harm reduction and integration. Dr. Lifschutz uses ketamine as a treatment for treatment-resistant depression, Post-Traumatic Stress Disorder, anxiety, suicidality, obsessive compulsive disorder, and substance abuse disorders in adult and adolescent patients. Trained in the administration of Ketamine, Dr. Lifschutz has been accepted to the Multidisciplinary Association for Psychedelic Studies (MAPS) training program for MDMA Assisted Psychotherapy once MDMA is legalized. Additionally, he is trained in Harm Reduction and the Integration of psychedelic drugs. For more information about Dr. David H. Lifschutz, please visit https://www.ketaminepsychiatrynyc.com/meet-dr-lifschutz.